Christmas comes early as Exopharm posts 100%+ gains.


Australian biopharmaceutical company Exopharm (ASX:EX1) is delivering bucket loads of Christmas joy today as trade opened at 1:30pm - take note Santa!

Limited access and strong backing ensured investors were in for treat as prices immediately gained over 100% on the IPOs ask, peaking at 43.5 cents before settling to 40 cents.

Exopharm is seeking to develop and then commercialise “exosomes” as therapeutic agents with the aim of increasing the human life span. That might sound the like stuff of science fiction, but today’s results are very real.

This will be one to watch in 2019 and congratulations to anyone who managed to get an allocation.